相关实验视频

Updated: May 24, 2025

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

全球功能基因组学揭示了GRK5作为一种囊性纤维化治疗点,与当前调节器具有协同作用

Hugo M Botelho¹, Miquéias Lopes-Pacheco¹, Madalena C Pinto^1,2

¹BioISI - Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisboa, Campo Grande, 1749-016 Lisboa, Portugal.

|March 5, 2025

概括

研究人员选了9000多个基因,以找到改善囊性纤维化 (CF) 超膜导电调节器 (CFTR) 蛋白质流量的方法. 抑制GRK5显示出拯救CFTR功能的希望,并为CF治疗提供了一个新的药物标.

科学领域:

分子生物学分子生物学
遗传学遗传学是一个
细胞生物学细胞生物学

背景情况:

囊性纤维化 (CF) 影响全球超过16万人,主要导致呼吸系统问题.
常见的p.Phe508del变体导致CF转膜导电性调节器 (CFTR) 蛋白错误折叠,阻止其运输到细胞表面.
目前的治疗方法为p.Phe508del-CFTR变异提供有限的肺功能改善 (∼14%).

研究的目的:

为了确定p.Phe508del-CFTR蛋白流量的全球调节者.
发现用于增强CFTR蛋白向血膜传递的新型治疗点.

主要方法:

对9000多个基因进行了基于显微镜的高含量小干扰RNA (siRNA) 选.
在人类呼吸道细胞中监测p.Phe508del-CFTR血 (PM) 救援.
通过二次siRNA查和机理学研究验证已识别的调节者.

主要成果:

在主屏幕中确定了p.Phe508del-CFTR流量的227个潜在调节者.
验证了35个调节器与额外的siRNAs.
确立了GRK5作为一个强大的调节器;它的抑制拯救了p.Phe508del-CFTR的PM流量和功能.

结论:

抑制GRK5代表了囊性纤维化的一种新疗法策略.
向GRK5可以改善p.Phe508del-CFTR在CF细胞中的贩运和功能.
这项研究确定了CF治疗的潜在新药标.

关键词:

细胞生物学细胞生物学功能性基因组学是一种功能性基因组学.

更多相关视频

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study

Published on: April 11, 2018

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

相关概念视频

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...